yabao pharmaceutical group-a
(600351:Shanghai Stock Exchange)
Transactions by YABAO PHARMACEUTICAL GROUP-A (600351) in the last 6 months
Shanxi Yabao Pharmaceutical Medicine Sales Co., Ltd. announced that it will receive CNY 40 million in an equity round of funding from existing investor, Yabao Pharmaceutical Group Co., Ltd. on October 29, 2014. The investor will maintain its stake at 100% in the company. The transaction has been approved in the 3rd session of the 6th directorate of the investor. The registered capital of the company will increase from CNY 10 million to CNY 50 million upon closing.
|No competitor information is available for 600351.|
|View Industry Companies|